NPI: 1578992491 · ISHPEMING, MI 49849 · Internal Medicine Physician · NPI assigned 11/02/2013
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 11/02/2013 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,661 | $401K |
| 2019 | 10,121 | $413K |
| 2020 | 8,355 | $330K |
| 2021 | 9,340 | $439K |
| 2022 | 11,684 | $567K |
| 2023 | 11,988 | $608K |
| 2024 | 8,270 | $470K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22,186 | 20,274 | $1.26M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14,694 | 13,862 | $1.13M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,230 | 1,225 | $116K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1,235 | 1,231 | $106K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,514 | 1,312 | $99K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,097 | 1,064 | $81K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,841 | 1,731 | $62K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4,541 | 4,388 | $43K |
| 99215 | Prolong outpt/office vis | 391 | 380 | $39K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 13 | 13 | $29K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1,907 | 1,802 | $28K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,162 | 2,123 | $28K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,667 | 1,593 | $27K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 361 | 356 | $27K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 212 | 200 | $17K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,021 | 839 | $13K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 186 | 181 | $13K |
| 91320 | 110 | 109 | $12K | |
| 90715 | 440 | 439 | $11K | |
| 90688 | 781 | 779 | $10K | |
| 90686 | 1,012 | 1,000 | $10K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 169 | 163 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 168 | 163 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 180 | 178 | $6K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 294 | 290 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 582 | 515 | $5K |
| 90480 | 113 | 112 | $4K | |
| 0134A | 93 | 93 | $3K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 25 | 25 | $3K |
| 90670 | 634 | 624 | $3K | |
| 90656 | 128 | 128 | $2K | |
| 90674 | 133 | 132 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 17 | 17 | $2K |
| 99460 | 38 | 37 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 30 | 30 | $2K |
| 99307 | 92 | 88 | $2K | |
| 99441 | 72 | 71 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 30 | 30 | $1K |
| 0124A | 33 | 33 | $1K | |
| 81002 | 401 | 398 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 96 | 91 | $920.00 |
| 81025 | 129 | 126 | $866.64 | |
| 99442 | 47 | 47 | $857.66 | |
| 96127 | 327 | 321 | $843.47 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 14 | 14 | $791.26 |
| 0064A | 27 | 26 | $678.74 | |
| 59025 | Fetal non-stress test | 23 | 13 | $624.22 |
| 90473 | 150 | 150 | $573.50 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 164 | 163 | $435.98 |
| 90651 | 12 | 12 | $229.34 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 15 | 15 | $149.22 |
| 90734 | 13 | 13 | $128.85 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 13 | 13 | $88.44 |
| 1160F | 1,193 | 1,145 | $0.00 | |
| 3078F | 645 | 631 | $0.00 | |
| 90633 | 80 | 80 | $0.00 | |
| 3077F | 93 | 90 | $0.00 | |
| 90461 | 54 | 54 | $0.00 | |
| 90685 | 47 | 39 | $0.00 | |
| 1036F | 984 | 924 | $0.00 | |
| 90680 | 217 | 216 | $0.00 | |
| 3079F | 425 | 417 | $0.00 | |
| 3080F | 52 | 50 | $0.00 | |
| 3008F | 1,381 | 1,341 | $0.00 | |
| 90698 | 230 | 230 | $0.00 | |
| 90723 | 87 | 82 | $0.00 | |
| 3075F | 190 | 187 | $0.00 | |
| 3074F | 785 | 767 | $0.00 | |
| 1125F | 30 | 29 | $0.00 | |
| 90744 | 25 | 25 | $0.00 | |
| 90647 | 38 | 37 | $0.00 |